These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10933662)

  • 1. Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid.
    Allegranzi B; Cazzadori A; Di Perri G; Bonora S; Berti M; Franchino L; Biglino A; Cipriani A; Concia E
    J Antimicrob Chemother; 2000 Aug; 46(2):319-22. PubMed ID: 10933662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
    Conte JE; Golden JA; Kelley MG; Zurlinden E
    Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.
    Wenzler E; Gotfried MH; Loutit JS; Durso S; Griffith DC; Dudley MN; Rodvold KA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7232-9. PubMed ID: 26349830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
    Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
    J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions.
    Kikuchi E; Kikuchi J; Nasuhara Y; Oizumi S; Ishizaka A; Nishimura M
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2799-803. PubMed ID: 19380601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
    Gotfried MH; Danziger LH; Rodvold KA
    J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens.
    Baldwin DR; Andrews JM; Wise R; Honeybourne D
    J Antimicrob Chemother; 1992 Sep; 30(3):377-85. PubMed ID: 1452503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets.
    Drusano GL; Lodise TP; Melnick D; Liu W; Oliver A; Mena A; VanScoy B; Louie A
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3406-12. PubMed ID: 21576431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of High-Dose Meropenem (Six Grams per Day) in Treatment of Experimental Murine Pneumonia Induced by Meropenem-Resistant Pseudomonas aeruginosa.
    Oshima K; Nakamura S; Iwanaga N; Takemoto K; Miyazaki T; Yanagihara K; Miyazaki Y; Mukae H; Kohno S; Izumikawa K
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
    Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
    Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy.
    Bergogne-Bérézin E; Muller-Serieys C; Aubier M; Dombret MC
    Eur J Clin Pharmacol; 1994; 46(1):87-8. PubMed ID: 8005193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
    Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
    Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem.
    So W; Crandon JL; Hamada Y; Nicolau DP
    J Antimicrob Chemother; 2016 Feb; 71(2):428-37. PubMed ID: 26559690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects.
    Andrews J; Honeybourne D; Jevons G; Boyce M; Wise R; Bello A; Gajjar D
    J Antimicrob Chemother; 2003 Mar; 51(3):727-30. PubMed ID: 12615879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.
    Cook PJ; Andrews JM; Wise R; Honeybourne D
    J Antimicrob Chemother; 1996 Feb; 37(2):331-9. PubMed ID: 8707743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of amikacin in bronchial epithelial lining fluid in neonates.
    Tayman C; El-Attug MN; Adams E; Van Schepdael A; Debeer A; Allegaert K; Smits A
    Antimicrob Agents Chemother; 2011 Sep; 55(9):3990-3. PubMed ID: 21709076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.
    Honeybourne D; Andrews JM; Cunningham B; Jevons G; Wise R
    J Antimicrob Chemother; 1999 Jan; 43(1):153-5. PubMed ID: 10381116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.
    Rodvold KA; Danziger LH; Gotfried MH
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2450-7. PubMed ID: 12878504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.